Decreased serum fibroblast growth factor - 2 levels in pre- and post-treatment patients with major depressive disorder

Neuroscience Letters

Volumn 579, Issue , 2014, Pages 168-172

  He, Shen ^a   Zhang, Tianhong ^a   Hong, Bo ^a   Peng, Daihui ^a   Su, Hui ^a   Lin, Zhiguang ^a   Fang, Yiru ^a   Jiang, Kaida ^a   Liu, Xiaohua ^a   Li, Huafang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Antidepressant; FGF 2; Major depressive disorder; Neuroplasticity; Serum treatment

Indexed keywords

ANTIDEPRESSANT AGENT; FIBROBLAST GROWTH FACTOR 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR DEPRESSION; MALE; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; ADOLESCENT; BLOOD; DEPRESSIVE DISORDER, MAJOR; FOLLOW UP; METABOLISM; MIDDLE AGED; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FIBROBLAST GROWTH FACTOR 2; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84907374004     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.07.035     Document Type: Article

References (25)

1. Bachis A., Mallei A., Cruz M.I., Wellstein A., Mocchetti I. Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neuron. Neuropharmacology 2008, 55:1114-1120.
2. Brunner G., Nguyen H., Gabrilove J., Rifkin D.B., Wilson E.L. Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 1993, 81:631-638.
3. Calabrese F., Molteni R., Gabriel C., Mocaer E., Racagni G., Riva M.A. Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine. Psychopharmacology (Berl.) 2011, 215:267-275.
4. Duman R.S., Li N. A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2012, 367:2475-2484.
5. Deguchi Y., Naito T., Yuge T., Furukawa A., Yamada S., Pardridge W.M., Kimura R. Blood-brain barrier transport of 125I-labeled basic fibroblast growth factor. Pharm. Res. 2000, 17:63-69.
6. Elsayed M., Banasr M., Duric V., Fournier N.M., Licznerski P., Duman R.S. Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression. Biol. Psychiatry 2012, 72:258-265.
7. Evans S.J., Choudary P.V., Neal C.R., Li J.Z., Vawter M.P., Tomita H., Lopez J.F., Thompson R.C., Meng F., Stead J.D., Walsh D.M., Myers R.M., Bunney W.E., Watson S.J., Jones E.G., Akil H. Dysregulation of the fibroblast growth factor system in major depression. Proc. Natl. Acad. Sci. U. S. A. 2004, 10:15506-15511.
8. Gonzalez A.M., Berry M., Maher P.A., Logan A., Baird A. A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain. Brain Res. 1995, 701:201-226.
9. Gaughran F., Payne J., Sedgwck P.M., Cotter D., Berry M. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. Brain Res. Bull. 2006, 70:221-227.
10. Hisaoka K., Tsuchioka M., Yano R., Maeda N., Kajitani N., Morioka N., Nakata Y., Takebayashi M. Tricyclic antidepressant amitriptyline activates fibroblast growth factor receptor signaling in glial cells: involvement in glial cell line-derived neurotrophic factor production. J. Biol. Chem. 2011, 286:21118-21128.
11. Jarosik J., Legutko B., Werner S., Unsicker K., von Bohlen Und Halbach O. Roles of exogenous and endogenous FGF-2 in animal models of depression. Restor. Neurol. Neurosci. 2011, 29:153-165.
12. Kahl K.G., Bens S., Ziegler K., Rudolf S., Kordon A., Dibbelt L., Schweiger U. Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder. Psychoneuroendocrinology 2009, 34:353-357.
13. Kim J., Gale K., Kondratyev A. Effects of repeated minimal electroshock seizures on NGF, BDNF and FGF-2 protein in the rat brain during postnatal development. Int. J. Dev. Neurosci. 2010, 28:227-232.
14. Mallei A., Shi B., Mocchetti I. Antidepressant treatments induce the expression of basic fibroblast growth factor in cortical and hippocampal neurons. Mol. Pharmacol. 2002, 61:1017-1024.
15. Marcus M., Yasamy M.T., van Ommeren M., Chisholm D., Saxena S. Depression 2012, WHO Department of Mental Health and Substance Abuse, World Health Organization, Geneva.
16. Rajkowska G., Stockmeier C.A. Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr. Drug Targets 2013, 11:1225-1236.
17. Reuss B., Unsicker K. Neuroglia 2005, 377-388. Oxford University Press, New York. 2nd ed. H. Kettenmann, B.R. Ransom (Eds.).
18. Reuss B., von Bohlen und Halbach O. Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res. 2003, 313:139-157.
19. Turner C.A., Calvo N., Frost D.O., Akil H., Watson S.J. The fibroblast growth factor system is downregulated following social defeat. Neurosci. Lett. 2008, 430:147-150.
20. Turner C.A., Gula E.L., Taylor L.P., Watson S.J., Akil H. Antidepressant-like effects of intracerebroventricular FGF2 in rats. Brain Res. 2008, 1224:63-68.
21. Takebayashi M., Hashimoto R., Hisaoka K., Tsuchioka M., Kunugi H. Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders. J. Neural Transm. 2010, 117:1119-1122.
22. Turner C.A., Watson S.J., Akil H. The fibroblast growth factor family: neuromodulation of affective behavior. Neuron 2012, 76:160-174.
23. Wagner J.P., Black I.B., DiCicco-Bloom E. Stimulation of neonatal and adult brain neurogenesis by subcutaneous injection of basic fibroblast growth factor. J. Neurosci. 1999, 14:6006-6016.
24. Weickert C.S., Kittell D.A., Saunders R.C., Herman M.M., Horlick R.A., Kleinman J.E., Hyde T.M. Basic fibroblast growth factor and fibroblast growth factor receptor-1 in the human hippocampal formation. Neuroscience 2005, 131:219-233.
25. Woodward W.R., Nishi R., Meshul C.K., Williams T.E., Coulombe M., Eckenstein F.P. Nuclear and cytoplasmic localization of basic fibroblast growth factor in astrocytes and CA2 hippocampal neurons. J. Neurosci. 1992, 12:142-152.